Moreover, ATF3 can sensitize GC cells to cisplatin by induction of ferroptosis via blocking Nrf2/Keap1/xCT signaling, supporting a promising therapeutic approach for overcoming chemoresistance in GC 80. This evidence concerns the gene ATF3 and gastric cancer.